Alnylam Pharmaceuticals
ALNY
#661
Rank
ยฃ24.11 B
Marketcap
ยฃ186.93
Share price
-8.48%
Change (1 day)
37.40%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company